- English version
- Articles
- Life Sciences
- Genetic engineering
- CRISPR/Cas9 system will be used to treat Leber's amaurosis
Related posts
-
Scientists are closer to curing blindness with the help of gene therapy
Geneticists from the USA have found another use for the CRISPR genomic editor, using it to remove mutations from stem cells of people suffering from retinal degeneration.
28 January 2016 -
Gene therapy of retinitis pigmentosa
Bioengineers from Cedars-Sinai Medical Center using the CRISPR/Cas9 system cured retinitis pigmentosa in rats – a dangerous hereditary disease that leads to blindness.
11 January 2016 -
A new method of gene therapy for Leber's amaurosis
The results exceeded expectations: gene therapy not only prevents the development of blindness, but also restores almost completely lost vision.
06 October 2015 -
The effect of gene therapy for blindness may be temporary
Three research groups reported contradictory results of gene therapy for a rare form of hereditary blindness – Leber's amaurosis: in some, the effect was "long-lasting", while others registered a gradual deterioration in the condition of patients.
05 May 2015 -
Choroideremia gene therapy: success is developing
With the help of gene therapy, scientists from the University of Oxford were able to partially restore vision to six more patients with a hereditary progressive form of blindness – choroideremia.
17 January 2014